Insulin signaling in the hippocampus has been targeted to improve impaired cognitive activity associated with diabetes mellitus and obesity (Fernandez and Torres-Alemán, 2012). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.